Latest Breaking News On - Cambridge based celsius therapeutics - Page 1 : comparemela.com

Cambridge biotech Agios will sell oncology business to Boston’s Servier for up to $2 billion The seller aims to focus on new therapies for genetic diseases By Anissa Gardizy Globe Staff,Updated December 21, 2020, 7:00 a.m. Email to a Friend Agios Pharmaceuticals Inc. has agreed to sell its oncology business to Boston’s Servier Pharmaceuticals in a deal worth up to $2 billion. Agios, of Cambridge, which has two cancer drugs on the market and others in testing, said Monday that it has decided to focus on drugs it is developing for genetic diseases. That portfolio is anchored by a medicine that could potentially

United statesDavid schenkeinJackie fouseServier pharmaceuticalsDrug administrationServier groupSeaport districtCambridge based celsius therapeuticsGoogle venturesஒன்றுபட்டது மாநிலங்களில்டேவிட் ஸ்ச்செங்கேன்துறைமுகம் மாவட்டம்கேம்பிரிட்ஜ் அடிப்படையிலானது செல்சியஸ் சிகிச்சைகூகிள் முயற்சிகள்